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ABSTRACT
Wagner DR, Shegrud K, Hintze KJ. ASEA Redox Supplement
Fails to Improve Aerobic Capacity and Ventilatory Threshold: A
Double-Blind, Placebo-Controlled Study. JEPonline 2019;22(4):2328. The ASEA redox cell signaling supplement beverage has been
commercially available for the past decade. Despite the market
longevity of this supplement, athletic sponsorship, and anecdotal
ergogenic claims, there is no independent, peer-reviewed research
on its efficacy. The purpose of this study was to determine if ASEA
improves aerobic capacity (VO2 max) and/or ventilatory threshold
(VT) of physically active subjects. Eleven (6 females, 5 males) young
adults (21.9 ± 3.9 yrs) performed 3 VO2 max tests: (a) baseline; (b)
after 2 wks of supplementing with ASEA; and (c) after 2 wks of
taking a placebo in a cross-over design. The treatment order was
randomized and double-blind. The subjects consumed 4 oz∙d-1 (118
mL∙d-1) of the ASEA treatment according to the manufacturer’s
recommendations. The subjects’ VO2 max values at baseline (55.0 ±
8.6 mL·kg-1·min-1), placebo (53.6 ± 9.1 mL·kg-1·min-1), and ASEA
(53.7 ± 10.1 mL·kg-1·min-1) were not significantly different (P=0.172).
Similarly, absolute VO2 max (P=0.436), time to reach VO2 max
(P=0.955), VT as a percentage of VO2 max (P=0.678), and maximal
heart rate (P=0.410) were not significantly different between trials.
Contrary to the manufacturer’s claims, ASEA did not improve the
aerobic performance of young, fit adults who supplemented with the
product daily for 2 wks.
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INTRODUCTION
Small physiological changes can result in meaningful improvements in health and physical
performance. Many people try to achieve these improvements with dietary supplementation.
Research suggests that 40% to 100% of athletes use supplements, depending on the
definition of supplements, the level of competition, and the type of sport (4).
One supplement manufacturer that boasts both health and performance claims for its product
is ASEA. The flagship product of ASEA is the redox cell signaling supplement beverage.
According to the company, this supplement contains “active redox signaling molecules” that
serve to protect, rejuvenate, and restore cells (aseaglobal.com). The specific redox signaling
molecules included in the ASEA beverage are not identified by the manufacturer, but one
research team noted that this supplement includes hydrogen superoxide, hydrogen peroxide,
hypochlorous acid, and nitric oxide (7). Knab et al. (6) described this supplement as “a saline
beverage with stable superoxide complexes.”
ASEA was founded in 2007, and their product has been commercially available for 10 yrs.
According to their web site, they sponsor 12 athletes that include paralympians, XTERRA and
Ironman triathletes, and world-class swimmers (https://aseaathletes.co). An in-house
unpublished report available on the Internet claimed that 4 oz∙d-1 (118 mL∙d-1) of ASEA for 2
wks improved maximal oxygen consumption (VO2 max) by 3%, time to reach VO2 max by
10%, and ventilatory threshold (VT) by 12% in a sample of 17 athletes (8). However, this
research was done without a control group. Also, the proposed mechanism explaining how
this cell signaling supplement could improve aerobic performance was not provided. Despite
ASEA being in business for over a decade, sponsorship of elite athletes, and a claim that
their product improves aerobic capacity, there is a dearth of peer-reviewed, scientific
research on this supplement. An extensive search of PubMed, Scopus, and GoogleScholar
revealed only two conference abstracts (6,9) and one foreign language publication (2) related
to ASEA and aerobic performance. Thus, the purpose of this study was to replicate the
manufacturer’s in-house report claiming improved aerobic performance with only 2 wks of
ASEA supplementation (8), but with the addition of a double-blind placebo control using a
cross-over design.
METHODS
Subjects
The subjects were recruited from the university campus community. Inclusion criteria
included being a regular aerobic exerciser (>150 min∙wk-1), a willingness to take the ASEA
supplement beverage and a placebo for 2 wks each, and complete 3 VO2 max tests.
Exclusion criteria included pregnancy and previously taking the ASEA supplement. The
subjects received the ASEA for free and were compensated $20 for their participation in the
study. The study was approved by the university’s institutional review board (protocol #7780),
and all subjects signed a written informed consent before beginning the study.
Design
The study was double-blind with neither the subjects nor the examiner conducting the VO2
max testing knowing which beverage, ASEA or placebo, was consumed. A cross-over design
was used such that each subject received both treatments, serving as his/her own control.
Additionally, the treatment order (ASEA first or placebo first) was randomly assigned.
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Procedures
All subjects underwent a baseline VO2 max test. Following baseline testing, the subjects were
given a 2-wk supply of a beverage in an unmarked container with a shot glass for measuring
the proper dosage. Subjects were instructed to take 2 oz (59 mL) in the morning and 2 oz (59
mL) in the evening (4 oz∙d-1; 118 mL∙d-1), daily, for 2 wks. Immediately before the VO2 max
test, the subjects consumed 8 oz (237 mL) of the beverage that they had been consuming for
the previous 2 wks. This is the dosing strategy recommended by ASEA, and it was consistent
with the protocol of Samuelson (8) from ASEA’s in-house testing. After 2 wks, the VO2 max
test was repeated. A 1-wk washout period with no treatment followed the second VO2 max
test. Following the washout week, the subjects were given the opposite treatment of what
they had received initially for another 2 wks. A third VO2 max test was given at the end of this
2-wk period.
The ASEA redox supplement was purchased directly from a commercial vendor. According to
the nutrition label, ASEA contains chloride (Cl) and sodium (Na). The active signaling
molecules suspended in the saline solution are not listed. To confirm the label ingredients,
ASEA was analyzed by inductively coupled plasma atomic emission spectroscopy at the
university’s analytical laboratory. This analysis revealed that ASEA has approximately the
same amount of NaCl as indicated on the nutrition label. Therefore, the placebo was
formulated using distilled water and contained the same amount of NaCl as ASEA (313 mg
per 118 mL serving). The placebo and ASEA were placed into non-descript, coded containers
by a researcher not involved in the VO2 max test to ensure that both the study subjects and
researchers conducting the performance tests were blinded to the experimental treatment.
VO2 Max Testing
The subjects’ height were measured to the nearest 0.1 cm with a wall-mounted stadiometer
(Seca 216, Seca Corp., Ontario, CA) and weight were measured to the nearest 0.1 kg with a
digital scale (Seca 869, Seca Corp., Ontario, CA). A ParvoMedics TrueMax 2400 Metabolic
Measurement System (ParvoMedics, Sandy, UT) was calibrated according to the
manufacturer’s instructions and used to analyze expired volumes of O 2 and CO2 for the
determination of VO2 max and VT. All subjects ran on a treadmill, but the protocol was
individualized in an attempt to have each subject reach maximal exertion in approximately 10
min (1). The speed and incline changes of each individual’s protocol were documented so
that each individual’s baseline testing protocol was repeated for the subsequent VO2 max
tests.
Various methods or techniques exist for determining VT, and each technique involves some
interpretation and subjective judgement (5). To eliminate investigator bias and subjectivity,
the default VT estimation from the ParvoMedics software was used. This software estimates
VT automatically using the v-slope method (M. P. Yeh, personal communication, September
25, 2017), such that VT is the point at which the slope of VO2 consumed plotted against
VCO2 produced increases from less than 1 to greater than 1.
Statistical Analyses
A priori power analysis (G-Power 3.0.10) for a one-way repeated measures ANOVA (baseline
v placebo v ASEA) with an alpha of 0.05 and power of 0.80, and assuming a correlation of
0.90 among the repeated measures suggested a sample size of 10 was sufficient to identify
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differences with an effect size of 0.20. The normality of the data was evaluated with a
Shapiro-Wilks test. Means and standard deviations were calculated, and differences in VO 2
max and VT across the three trials were evaluated with a one-way repeated measures
ANOVA. A P-value of <0.05 was considered statistically significant. All statistical analyses
were done using SPSS (version 25, IBM, Inc., Armonk, NY).
RESULTS
Twelve subjects were enrolled in the study, but one male suffered an injury unrelated to the
study and was unable to complete all 3 trials. Therefore, all statistical analyses were done on
11 subjects (6 females, 5 males). The physically active subjects were homogeneous with
regard to age (21.9 ± 3.9 yrs) and body mass index (23.7 ± 2.2 kg∙m-2). All data were
normally distributed (P>0.05) with no statistical outliers. There were no significant withinsubject differences (P>0.05) across trials for relative and absolute VO2 max, time to reach
maximal exertion, maximal heart rate, and VT (Table 1).
Table 1. Trial Comparison of Measured Variables.
Variable

Baseline

Placebo

VO2 max (mL·kg-1∙min-1)

55.0  8.6

53.6  9.1

VO2 max (L∙min-1)

4.01  0.88

3.94  0.97

3.96  1.06

0.436

Time to VO2 max (sec)

723  129

721  132

725  112

0.955

192.1  8.5

190.3  9.8

191.6  6.1

0.410

72.6  2.1

73.2  4.7

74.3  8.9

0.678

Maximal Heart Rate
(beats∙min-1)

Ventilatory Threshold
(%)

ASEA
53.7  10.1

P-value
0.172

DISCUSSION
The results from this study indicate that daily intake of the ASEA redox supplement for 2 wks
had no effect on measures of aerobic performance. In fact, the differences in VO 2 across
trials were so small that they were less than the reported test-retest reliability of VO2 testing
with the ParvoMedics system (3). This study stands in contrast to the in-house report by
Samuelson (8) and the work by Barghini and Maffi (2). Samuelson (8) reported that about
70% of the athletes experienced improvements using the same 2-wk ASEA supplementation
dosing strategy employed in the present study. However, Samuelson (8) had no placebo
control. Similarly, Barghini and Maffi (2) reported that 9 of 10 recreational runners improved
their 10 km run time by 2 to 3 min following 3 wks of supplementing 120 mL∙d-1 of ASEA.
However, again, there was no control group. Thus, the improvement could have been due
simply to aerobic training. Furthermore, it was discovered that one of the authors served on
the ASEA science advisory council. To our knowledge, the present study is the first
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independent, peer-reviewed, placebo-controlled investigation of ASEA’s ability to effect
aerobic performance to reach publication.
Despite the null result in the present investigation, two conference abstracts by the same
research lab suggested a potential ergogenic benefit of the ASEA redox supplement. In 2012,
Shanely et al. (9) reported that only 1 wk of 118 mL∙d-1 of ASEA supplementation enhanced
fatty acid mobilization over a placebo. However, this did not improve performance on a 75 km
cycling time trial nor did ASEA alter biomarkers of inflammation, oxidative stress, or immunity.
The following year, Knab et al. (6) reported that ASEA-supplemented mice run to exhaustion
had increased skeletal muscle phosphorylated acetyl-CoA carboxylase over placebo mice.
The ASEA-supplemented mice ran 29% longer than the placebo group, and the authors
theorized that this was the result of muscle glycogen sparing due to less inhibition of fatty
acid oxidation. The findings from these two abstracts suggest that the greatest ergogenic
benefit to ASEA supplementation might be long duration events in which glycogen depletion
is the limiting factor rather than maximal aerobic efforts as was tested in the present study.
There are claims on the ASEA website that the redox signaling beverage enhances recovery.
The efficacy of this supplement to speed recovery following aerobic exercise was not part of
the present study. However, Ryan et al. (7) reported that a single dose of ASEA was
ineffective at improving recovery from a weight lifting bout or alleviating delayed onset muscle
soreness.
Strengths and Limitations
This was the first independent, randomized, placebo-controlled, double-blind study of ASEA.
Thus, the study design and absence of conflict of interest were strengths of this study. While
2 wks may not be enough time to observe meaningful improvements in VO2 max or VT, this
time span for supplementation was selected because it matched the study duration used by
Samuelson (8), and our goal was to replicate the manufacturer’s research. Also, the results
were limited to the performance variables of VO2 max and VT. The conference abstract of
Shanely et al. (9) showed that it is possible for the metabolite profiles of ASEA users to be
altered without changes in aerobic performance.
CONCLUSIONS
In summary, 2 wks of 118 mL∙d-1 (4 oz∙d-1) of the ASEA redox supplement had no effect on
the aerobic capacity, VT, or time to achieve VO2 max compared to baseline testing and a
placebo in a group of young, physically active adults. Other claims of the benefits of ASEA
supplementation, such as extending time to fatigue or enhancing recovery remain untested.
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